X @Bloomberg
Bloomberg·2025-12-16 15:32
US-listed biotech and pharma company share sales are staging a late-year revival, with M&A in the industry boosting valuations and stoking additional demand https://t.co/M7fHJQVbeL ...
US-listed biotech and pharma company share sales are staging a late-year revival, with M&A in the industry boosting valuations and stoking additional demand https://t.co/M7fHJQVbeL ...